Broad-spectrum multi-epitope recombinant vaccine for bovine foot-and-mouth disease virus type A strain epidemic abroad, and preparation method and application thereof
A technology of foot-and-mouth disease vaccine and epidemic strains, which is applied in the field of veterinary vaccine research and can solve the problems of biosafety acceleration
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0029] The preparation of embodiment 1 broad-spectrum multi-epitope recombinant antigen of bovine type A foot-and-mouth disease epidemic strain abroad
[0030] 1. Bioinformatics analysis of VP1 gene of type A foot-and-mouth disease virus:
[0031] The structural protein VP1 of foot-and-mouth disease virus is the dominant antigen of the virus. Whether it is the isolated and purified natural VP1 protein or the recombinant expression product, it can induce the body to produce protective neutralizing antibodies, which is type-specific. The VP1 gene of type A foot-and-mouth disease virus has a full length of 639 nucleotides, encoding a protein consisting of 213 amino acids, and its main antigenic epitopes are concentrated in the 140-160 amino acid and 200-213 amino acid segments. In this study, DNAStar biological software was used to analyze the sequence of representative bovine type A foot-and-mouth disease virus strains (NCBI accession numbers: FJ755067, HQ666886 and AY59371) rec...
Embodiment 2
[0037] Example 2 Preparation of broad-spectrum multi-epitope vaccine of bovine type A foot-and-mouth disease epidemic strains abroad and analysis of immune efficacy
[0038] 1. Vaccine preparation:
[0039] The purified protein was quantified by the Bio-Rad quantitative kit and diluted to an appropriate concentration, alone or with the purified 3D protein full-length fragment (the amino acid sequence is shown in SEQ ID NO.8, and the nucleotide sequence encoding it is shown in SEQ ID NO .7) and the recombinant antigen at a ratio of 1:2 (V / V), then added an equal volume of oil adjuvant ISA206 (France) to emulsify into a vaccine preparation.
[0040] 2. Guinea pig immune efficacy test:
[0041] Using the prepared vaccine, 0.2ml of each guinea pig was inoculated by intramuscular route (20μg antigen or 20μg antigen + 10μg 3D protein) to immunize 5 guinea pigs respectively. The results of the immunization experiment showed that no matter whether the recombinant antigen alone or com...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com